Cardiac care of patients with cardiac amyloidosis

Osnat Itzhaki Ben Zadok, Ran Kornowski

Research output: Contribution to journalReview articlepeer-review


Cardiac amyloidosis, the majority of cases of which are due to immunoglobulin light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR), affects different aspects of the heart and cardiovascular system. Amyloid-induced cardiomyopathy, clinically manifesting with heart failure and electrophysiological abnormalities, has distinct characteristics compared to non-amyloid cardiomyopathies. Accordingly, specific management strategies are required. This paper will review the cardiovascular manifestations of patients with cardiac amyloidosis and their suggested treatment strategies, emphasizing the importance of multidisciplinary care.

Original languageEnglish
Pages (from-to)343-351
Number of pages9
JournalActa Haematologica
Issue number4
StatePublished - 1 Jul 2020


  • Cardiac amyloidosis
  • Immunoglobulin light chain amyloidosis
  • Transthyretin amyloidosis


Dive into the research topics of 'Cardiac care of patients with cardiac amyloidosis'. Together they form a unique fingerprint.

Cite this